SCI
WST icon

S&CO Inc’s West Pharmaceutical WST Stock Holding History

S&CO Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,600
Closed -$851K – 220
2024
Q4 		$851K Hold
2,600
– – 0.06% 145
2024
Q3 		$780K Hold
2,600
– – 0.05% 154
2024
Q2 		$856K Buy
2,600
+200
+8% +$70.7K 0.06% 148
2024
Q1 		$949K Buy
+2,400
New +$888K 0.07% 134

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

S&CO Inc's WST Position: Q1 2025 in Review

S&CO Inc sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 2,600 shares — an estimated $851K sold.

S&CO Inc first reported a position in WST in Q1 2024 and held it in 4 quarters. The position peaked at $949K in Q1 2024. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • S&CO Inc reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • S&CO Inc sold 2,600 West Pharmaceutical shares in Q1 2025, an estimated $851K.
  • S&CO Inc first reported a position in West Pharmaceutical in Q1 2024 and held it in 4 quarters.
  • S&CO Inc's West Pharmaceutical position peaked at $949K in Q1 2024.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on S&CO Inc's 13F filing for Q1 2025, filed 8 May 2025.